Pharmacology

Action Mechanism of Action Reference
AGONIST Insulin receptor agonist FDA

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Diabetes Mellitus 3 D003920 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Endocrine disorders
25.0
Injury, poisoning and procedural complications
25.0
Metabolism and nutrition disorders
25.0
Psychiatric disorders
25.0

Cross References

Resources Reference
ChEMBL CHEMBL1201644